The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment
Open accessAbstract
Designing studies to examine hepatitis C virus (HCV) transmission via the shared use of drug injection paraphernalia other than syringes is difficult because of saturation levels of HCV infection in most samples of injection drug users (IDUs). The authors measured the incidence of HCV infection in a large cohort of young IDUs from Chicago, Illinois, and determined the risk of HCV seroconversion associated with specific forms of sharing injection paraphernalia. From 1997 to 1999, serum samples obtained from 702 IDUs aged 18-30 years were screened for HCV antibodies; prevalence was 27%. Seronegative participants were tested for HCV antibodies at baseline, at 6 months, and at 12 months. During 290 person-years of follow-up, 29 participants seroconverted (incidence: 10.0/100 person-years). The adjusted relative hazard of seroconversion, controlling for demographic and drug-use covariates, was highest for sharing "cookers" (relative hazard = 4.1, 95% confidence interval: 1.4, 11.8), followed by sharing cotton filters (relative hazard = 2.4, 95% confidence interval: 1.1, 5.0). Risks associated with syringe-sharing and sharing of rinse water were elevated but not significant. After adjustment for syringe-sharing, sharing cookers remained the strongest predictor of seroconversion (relative hazard = 3.5, 95% confidence interval: 1.3, 9.9). The authors conclude that sharing of injection equipment other than syringes may be an important cause of HCV transmission between IDUs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations
Heckathorn, D. D. (1997) · Social Problems · doi:10.1525/sp.1997.44.2.03x0221m · Cited by 4,409
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data
Turnbull, B. W. (1976) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1976.tb01597.x · Cited by 1,828
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.655 · Cited by 690
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Sharing of drug preparation equipment as a risk factor for hepatitis C
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.42 · Cited by 500
Hepatitis C in Hospital Employees with Needlestick Injuries
Kiyosawa, K., Sodeyama, T., Tanaka, E., Nakano, Y., Furuta, S., Nishioka, K., Purcell, R. H., & Alter, H. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-367 · Cited by 330
High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus
Esteban, R., López-Talavera, J. C., Genescà, J., Madoz, P., Viladomiu, L., Muñiz‐Díaz, E., Martin-Vega, C., Rosell, M., Allende, H., Vidal, X., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-443 · Cited by 296
Maintaining Low HIV Seroprevalence in Populations of Injecting Drug Users
Des Jarlais, D. C. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530150050033 · Cited by 279
Syringe Exchange and Risk of Infection with Hepatitis B and C Viruses
Hagan, H., McGough, J. P., Thiede, H., Weiss, N. S., Hopkins, S., & Alexander, E. R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009792 · Cited by 256
Hepatitis C virus infection in the United States
Alter, M. J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80381-x · Cited by 235
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., & Thomas, D. L. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3274-3277.1997 · Cited by 227
Effect of Human Immunodeficiency Virus on Hepatitis C Virus Infection among Injecting Drug Users
Thomas, D. L., Shih, J. W., Alter, H. J., Vlahov, D., Cohn, S., Hoover, D. R., Cheung, L., & Nelson, K. E. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.4.690 · Cited by 226
Prevalence, Incidence, and Risk Factors of Hepatitis C Virus Infection among Drug Users in Amsterdam
van den Hoek, J. A. R., van Haastrecht, H. J. A., Goudsmit, J., de Wolf, F., & Coutinho, R. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.4.823 · Cited by 182
Transmission of Hepatitis C Virus: Rates, Routes, and Cofactors
MacDonald, M., Crofts, N., & Kaldor, J. (1996) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017921 · Cited by 168
Thorpe, L. E., Ouellet, L. J., Levy, J. R., Williams, I. T., & Monterroso, E. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/317607 · Cited by 160
Self-citationAn overview of the effectiveness and efficiency of HIV prevention programs.
Holtgräve, D. R., Qualls, N., Curran, J. W., Valdiserri, R. O., Guinan, M. E., & Parra, W. C. (1995) · Europe PMC (PubMed Central) · Cited by 158
Needle sharing among intravenous drug abusers : national and international perspectives
Battjes, R. J., & Pickens, R. W. (1988) · University of Michigan Library Repository · Cited by 124
Donahue, J. G., Nelson, K. E., Mufioz, A., Vlahov, D., Rennie, L. L., Taylor, E., Saah, A. J., Cohn, S., Odaka, N., & Farzadegan, H. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116023 · Cited by 122
Wiebel, W. W., Jimenez, A. D., Johnson, W. A., Ouellet, L. J., Jovanovic, B. D., Lampinen, T. M., Murray, J., & O’Brien, M. U. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199607000-00008 · Cited by 111
Shah, S. M. A., Shapshak, P., Rivers, J. E., Stewart, R. V., Weatherby, N. L., Xin, K.-Q., Page, J. B., Chitwood, D. D., Mash, D. C., Vlahov, D., et al. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199603010-00010 · Cited by 95
Stephens, R. C., Feucht, T. E., & Roman, S. W. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.5.568 · Cited by 84
Bluthenthal, R. N., Kral, A. H., Erringer, E. A., & Edlin, B. R. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199808150-00013 · Cited by 82
Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993
HUNTER, G. M., Donoghoe, M. C., Stimson, G. V., Rhodes, T., & Chalmers, C. P. (1995) · AIDS · doi:10.1097/00002030-199505000-00012 · Cited by 79
The Prevalence of Additional Injection-Related HIV Risk Behaviors Among Injection Drug Users
Koester, S. K., Booth, R. E., & Zhang, Y. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199606010-00015 · Cited by 79
Watters, J. K. (1994) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199412000-00009 · Cited by 69
HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1
Clatts, M. C., Heimer, R. R., Abdala, N., et al. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199910010-00013 · Cited by 66
Feldman, H. W., & Biernacki, P. (1988) · PsycEXTRA Dataset · doi:10.1037/e471142004-001 · Cited by 63
Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model.
Ww, W. (1988) · PubMed · Cited by 59
Preventing AIDS in Drug Users and Their Sexual Partners
Collins, C. B., DiClemente, R. J., Sorensen, J. L., Wermuth, L., Gibson, D. R., Choi, K.-H., Guydish, J. R., & Batki, S. L. (1996) · Family Relations · doi:10.2307/585300 · Cited by 44
Nicolosi, A., Molinari, S., Musicco, M., SARACCO, A., Ziliani, N., & Lazzarin, A. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb02632.x · Cited by 42
THE NATURAL HISTORY OF HEPATITIS C VIRUS INFECTION
Kenny-Walsh, E. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70204-x · Cited by 32
Colón, H. M., Sahai, H., Robles, R. R., & Matos, T. D. (1995) · AIDS Education and Prevention · doi:10.1521/aeap.1995.7.3.195 · Cited by 25
Correlates of Hepatitis C Virus Infection Among Injection Drug Users
Cohn, S., Thomas, D. L., Vlahov, D., Solomon, L., Taylor, E. G., Garfein, R. S., & Nelson, K. E. (1995) · Cited by 16
Replication of hepatitis C virus
Yoshikura, H., Hijikata, M., Nakajima, N., & Shimizu, Y. K. (1996) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1996.tb00074.x · Cited by 12
Cited by
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Epidemiology of hepatitis C virus infection
Alter, M. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i17.2436 · Cited by 1,339
Epidemiology of viral hepatitis and HIV co-infection
Alter, M. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.004 · Cited by 1,012
Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304132 · Cited by 698
Metadata
- Authors
- Thorpe, L. E.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04-01
- Volume
- 155
- Issue
- 7
- Pages
- 645-653
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2132432704
- Cited by
- 444
- References
- 40
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.